1 |
SAEEDI P, PETERSOHN I, SALPEA P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition[J]. Diabetes Res Clin Pract, 2019, 157(10):107843. doi:10.1016/j.diabres.2019.107843
doi: 10.1016/j.diabres.2019.107843
|
2 |
DAMANIK J, YUNIR E. Type 2 diabetes mellitus and cognitive impairment[J]. Acta Med Indones, 2021, 53(2):213-220.
|
3 |
MARTINEZ M, SANTAMARINA J, PAVESI A, et al. Glycemic variability and cardiovascular disease in patients with type 2 diabetes[J]. BMJ Open Diabetes Res Care, 2021, 9(1):e002032. doi:10.1136/bmjdrc-2020-002032
doi: 10.1136/bmjdrc-2020-002032
|
4 |
PITTAS A G, KAWAHARA T, JORDE R, et al. Vitamin D and risk for type 2 diabetes in people with prediabetes: A systematic review and meta-analysis of individual participant data from 3 randomized clinical trials[J]. Ann Intern Med, 2023, 176(3):355-363. doi:10.7326/m22-3018
doi: 10.7326/m22-3018
|
5 |
AHMADIAN F, RAZMPOOSH E, EJTAHED H S, et al. Effects of probiotic supplementation on major cardiovascular-related parameters in patients with type-2 diabetes mellitus: A secondary-data analysis of a randomized double-blind controlled trial[J]. Diabetol Metab Syndr, 2022, 14(1):52. doi:10.1186/s13098-022-00822-z
doi: 10.1186/s13098-022-00822-z
|
6 |
YANG T, LIU Y J, LI L C, et al. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: A RCSCD-TCM study in China[J]. Cardiovasc Diabetol, 2022, 21(1):93. doi:10.1186/s12933-022-01531-7
doi: 10.1186/s12933-022-01531-7
|
7 |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4):315-409.
|
8 |
中国营养学会健康管理分会. 维生素D营养状况评价及改善专家共识[J]. 中华健康管理学杂志, 2023, 17(4):245-252.
|
9 |
KIM H J, KIM K I. Blood pressure target in type 2 diabetes mellitus[J]. Diabetes Metab J, 2022, 46(5):667-674. doi:10.4093/dmj.2022.0215
doi: 10.4093/dmj.2022.0215
|
10 |
MARTENS T, BECK R W, BAILEY R, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial[J]. JAMA, 2021, 325(22):2262-2272.
|
11 |
陈锦文, 郭立新. 住院患者糖尿病构成比及糖尿病血糖控制情况对平均住院时间的影响[J]. 中华糖尿病杂志, 2022, 14(12):1417-1422.
|
12 |
CHIANG H Y, LIN K R, HSIAO Y L, et al. Association between preoperative blood glucose level and hospital length of stay for patients undergoing appendectomy or laparoscopic cholecystectomy[J]. Diabetes Care, 2021, 44(1):107-115. doi:10.2337/dc19-0963
doi: 10.2337/dc19-0963
|
13 |
MANOUSAKI D, HARROUD A, MITCHELL R E, et al. Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study[J]. PLoS Med, 2021, 18(2):e1003536. doi:10.1371/journal.pmed.1003536
doi: 10.1371/journal.pmed.1003536
|
14 |
HARRIS E. Meta-analysis: Vitamin D therapy reduced type 2 diabetes[J]. JAMA, 2023, 329(9):703. doi:10.1001/jama.2023.1550
doi: 10.1001/jama.2023.1550
|
15 |
VONDRA K, HAMPL R. Vitamin D and new insights into pathophysiology of type 2 diabetes[J]. Horm Mol Biol Clin Investig, 2021, 42(2):203-208. doi:10.1515/hmbci-2020-0055
doi: 10.1515/hmbci-2020-0055
|
16 |
何心, 魏伟, 周思芮, 等. 不同程度T2DM合并DR患者糖脂代谢指标、血清25(OH)D和VEGF水平的变化及临床意义[J]. 海南医学, 2023, 34(11):1552-1555.
|
17 |
CHEN X, WAN Z Z, GENG T T, et al. Vitamin D status, Vitamin D receptor polymorphisms, and risk of microvascular complications among individuals with type 2 diabetes: A prospective study[J]. Diabetes Care, 2023, 46(2):270-277. doi:10.2337/dc22-0513
doi: 10.2337/dc22-0513
|
18 |
RASOULI N, BRODSKY I G, CHATTERJEE R, et al. Effects of Vitamin D supplementation on insulin sensitivity and secretion in prediabetes[J]. J Clin Endocrinol Metab, 2022, 107(1):230-240. doi:10.2337/db21-301-or
doi: 10.2337/db21-301-or
|
19 |
ARGANO C, MIRARCHI L, AMODEO S, et al. The role of Vitamin D and its molecular bases in insulin resistance, diabetes, metabolic syndrome, and cardiovascular disease: state of the art[J]. Int J Mol Sci, 2023, 24(20):15485. doi:10.3390/ijms242015485
doi: 10.3390/ijms242015485
|
20 |
SAID J, LAGAT D, KIMAINA A, et al. Beta cell function, insulin resistance and vitamin D status among type 2 diabetes patients in Western Kenya[J]. Sci Rep, 2021, 11(1):4084. doi:10.1038/s41598-021-83302-0
doi: 10.1038/s41598-021-83302-0
|
21 |
CHE B, ZHONG C, ZHANG R, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: An analysis of UK biobank data[J]. Cardiovasc Diabetol, 2023, 22(1):34. doi:10.1186/s12933-023-01762-2
doi: 10.1186/s12933-023-01762-2
|
22 |
刘小位. TG/HDL-C与新诊断T2DM患者胰岛素抵抗和β细胞功能的相关性研究[D]. 延安:延安大学, 2017.
|
23 |
REBELLO C J, MORALES T S, CHUON K, et al. Physiologic hormone administration improves HbA1C in Native Americans with type 2 diabetes: A retrospective study and review of insulin secretion and action[J]. Obes Rev, 2023, 24(12):e13625. doi:10.1111/obr.13625
doi: 10.1111/obr.13625
|
24 |
ZHONG J D, CHEUNG C Y Y, SU X L, et al. Specific triacylglycerol, diacylglycerol, and lyso-phosphatidylcholine species for the prediction of type 2 diabetes: A ~ 16-year prospective study in Chinese[J]. Cardiovasc Diabetol, 2022, 21(1):234. doi:10.1186/s12933-022-01677-4
doi: 10.1186/s12933-022-01677-4
|
25 |
HOLT R, PETERSEN J H, DINSDALE E, et al. Vitamin D supplementation improves fasting insulin levels and HDL cholesterol in infertile men[J]. J Clin Endocrinol Metab, 2022, 107(1):98-108. doi:10.1210/clinem/dgab667
doi: 10.1210/clinem/dgab667
|
26 |
SUN L J, LU J X, LI X Y, et al. Effects of vitamin D supplementation on glucose and lipid metabolism in patients with type 2 diabetes mellitus and risk factors for insulin resistance[J]. World J Diabetes, 2023, 14(10):1514-1523. doi:10.4239/wjd.v14.i10.1514
doi: 10.4239/wjd.v14.i10.1514
|